Health In Tech, Inc.
NASDAQ:HITSoftware - Application
+$0.00 today
- Market cap
- $50.13M
- Beta
- 2.94
- P/E (TTM)
- -75.2
- EPS (TTM)
- -$0.01
Volume 0.04M
Average 0.23M
HIT Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Health In Tech, Inc.NASDAQ: HIT
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 36.3% from a year ago
Cash & equivalents stood at $10.33M at the end of Q1 FY2026, up 36.3% from a year earlier and up 34.6% from the prior quarter. Over 3 fiscal years it compounded at +72.7% a year.
Context
- Cash & equivalents amounted to 35.6% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +36.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 7.67M USD
- Year-over-year change
- -2.3%
- 3-year CAGR
- +72.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.67M | -2.3% |
| FY2024 | 2024-12-31 | 7.85M | +224.8% |
| FY2023 | 2023-12-31 | 2.42M | +62.4% |
| FY2022 | 2022-12-31 | 1.49M | — |
Cash & Equivalents vs competitors
How HIT compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +36.3% is the 3rd highest of 8, against a peer median of -22.3%.
- Cash & equivalents amounts to 35.6% of total assets for HIT, versus a peer median of 13.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LAWRRobot Consulting Co., Ltd. ADS | Sep 2025 | ¥605.35M JPY | +149.0% | -28.6% | 43.4% |
| Mar 2026 | $185.69M USD | +6.8% | -2.6% | 42.3% | |
| Mar 2026 | $86.25M USD | +44.6% | -15.3% | 45.3% | |
TEADTeads Holding Co. | Mar 2026 | $85.49M USD | -37.3% | +6.7% | 7.1% |
| Mar 2026 | $36.59M USD | -37.5% | -17.7% | 13.0% | |
SVCOSilvaco Group, Inc. Common Stock | Mar 2026 | $10.93M USD | -63.0% | +18.0% | 9.8% |
HITHealth In Tech, Inc. | Mar 2026 | $10.33M USD | +36.3% | +72.7% | 35.6% |
| Dec 2025 | $4.02M USD | -22.3% | +10.9% | 5.8% | |
| Peer median (excluding HIT) | — | -22.3% | -2.6% | 13.0% | |
Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Health In Tech, Inc.
NASDAQ:HIT
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.